Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.

MLA

Blicklé, J. F., et al. “Insulin Glargine Provides Greater Improvements in Glycaemic Control vs. Intensifying Lifestyle Management for People with Type 2 Diabetes Treated with OADs and 7-8% A1c Levels. The TULIP Study.” Diabetes, Obesity & Metabolism, vol. 11, no. 4, Apr. 2009, pp. 379–86. EBSCOhost, https://doi.org/10.1111/j.1463-1326.2008.00980.x.

APA

Blicklé, J.-F., Hancu, N., Piletic, M., Profozic, V., Shestakova, M., Dain, M.-P., Jacqueminet, S., & Grimaldi, A. (2009). Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. Diabetes, Obesity & Metabolism, 11(4), 379–386. https://doi.org/10.1111/j.1463-1326.2008.00980.x

Chicago

Blicklé, J-F, N Hancu, M Piletic, V Profozic, M Shestakova, M-P Dain, S Jacqueminet, and A Grimaldi. 2009. “Insulin Glargine Provides Greater Improvements in Glycaemic Control vs. Intensifying Lifestyle Management for People with Type 2 Diabetes Treated with OADs and 7-8% A1c Levels. The TULIP Study.” Diabetes, Obesity & Metabolism 11 (4): 379–86. doi:10.1111/j.1463-1326.2008.00980.x.